The information contained on this website is intended exclusively for healthcare professionals qualified to prescribe, dispense or recommend medicinal products.

Close-up of a blue-gloved hand holding an vial of injectable medicine at the Ferrer production plant.

Business

PRODUCTS

We specialize in own-brand prescription drugs, mainly for hospital use

As a pharmaceutical company, we contribute to health, a fundamental human right and an essential condition for exercising all other individual and collective rights. A necessary foundation for social justice.

 

After more than 65 years of activity, we have significant experience and specialization in the areas of neurology, cardiovascular intensive care, Cardiometabolism and pain management.

 

With the goal of providing meaningful and distinctive value to people suffering from severe conditions, Ferrer is increasingly focusing on two therapeutic areas: pulmonary vascular and interstitial lung diseases and rare neurological diseases.

56 results found

  • Product

    Tyvaso

    Product Type

    Medicinal product

    Active ingredient

    Inhaled treprostinil

    Therapeutic area

    Cardiovascular/Respiratory

  • Product

    Ub test

    Product Type

    Medicinal product (for diagnostic use)

    Active ingredient

    13-C UREA

    Therapeutic area

    Gastroenterology

  • Product

    Valdoxan

    Product Type

    Medicinal product

    Active ingredient

    Agomelatine

    Therapeutic area

    Neurology

  • Product

    Vastarel

    Product Type

    Medicinal product

    Active ingredient

    Trimetazidine

    Therapeutic area

    Cardiovascular

  • Product

    Wakix

    Product Type

    Medicinal product

    Active ingredient

    Pitolisant

    Therapeutic area

    Neurology

  • Product

    Zalain

    Product Type

    Medicinal product

    Active ingredient

    Sertaconazole

    Therapeutic area

    Dermatology

HEALTHCARE PROFESSIONALS

At Ferrer we ensure that the medical community is reliably informed about the use and administration of our medicinal products.

Last updated: July 2026